Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SLN
HOLDSilence Therapeutics plc · Healthcare · United Kingdom · $521M · Avg Vol: $7M/d
36
StockRankGet insider-trade alerts
Q
26
V
21
M
81
P/E (TTM)
—
ROE
-92.6%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)+80.4%
SMA 50SMA 200
Close
$12.07
RSI (14)
64.7
52W High
$12.19
From 52W High
1.0%
SCORE BREAKDOWN
Quality
26
ROIC
-65.4%11.0
ROE
-92.6%9.8
GP/Assets
0.5%12.3
Op. Margin
-3565.4%4.4
FCF/Assets
-47.4%5.9
Piotroski
239.0
Int. Cover
—N/A
D/E Ratio
0.00x90.9
Current Ratio
9.83x86.2
Value
21
P/E (TTM)
—N/A
EV/EBITDA
-6.3x25.0
P/FCF
—N/A
P/B
10.5x10.6
P/S
620.4x3.4
Div Yield
—N/A
Momentum
81
52W High %
99%98.6
RS 6M
105%98.0
SMA 50/200
1.24x91.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+76%66.3
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$521M
P/E (Forward)
-28.3x
Gross Margin
79.5%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SLN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SLN | Silence Therapeutics plc(you) | $521M | 36 | HOLD |
| AUTL | Autolus Therapeutics plc | $386M | 32 | SELL |
| AVCT.L | Avacta Group Plc | $489M | 12 | STRONG SELL |
| OXB.L | Oxford Biomedica plc | $1.0B | 14 | STRONG SELL |
| IMCR | Immunocore Holdings plc | $1.8B | 48 | HOLD |
| SCLP.L | Scancell Holdings plc | $252M | 10 | STRONG SELL |
| BCYC | Bicycle Therapeutics plc | $270M | 8 | STRONG SELL |
| ONT.L | Oxford Nanopore Technologies plc | $1.6B | 16 | STRONG SELL |
| GNS.L | Genus plc | $1.9B | 54 | HOLD |
| POLB.L | Poolbeg Pharma PLC | $63M | 24 | SELL |
Peer medians: ROE 0.2% · P/E 24.7x · Gross margin 55.5%